Solarvest Bioenergy Inc
XTSX:SVS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its Industry Average (5.1), the stock would be worth CA$-0.09 (469% downside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -1.4 | CA$0.03 |
0%
|
| Industry Average | 5.1 | CA$-0.09 |
-469%
|
| Country Average | 10.2 | CA$-0.18 |
-835%
|
Forward EV/EBITDA
Today’s price vs future ebitda
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| CA |
|
Solarvest Bioenergy Inc
XTSX:SVS
|
1.5m CAD | -1.4 | -0.5 | |
| US |
G
|
GE Vernova LLC
NYSE:GEV
|
270.3B USD | 0 | 0 | |
| UK |
E
|
Eight Capital Partners PLC
F:ECS
|
158.4B EUR | 0 | 0 | |
| US |
C
|
China Industrial Group Inc
OTC:CIND
|
121B USD | 3 417.4 | 4 020.7 | |
| NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
103.1B ZAR | 14.4 | 10.7 | |
| US |
F
|
Fintech Ecosystem Development Corp
NASDAQ:FEXD
|
67.9B USD | -17 953.8 | 38 341.6 | |
| US |
C
|
CoreWeave Inc
NASDAQ:CRWV
|
58.7B USD | 0 | 0 | |
| CH |
G
|
Galderma Group AG
SIX:GALD
|
36.8B CHF | 0 | 0 | |
| US |
|
Coupang Inc
F:788
|
33.9B EUR | 34.7 | 187.5 | |
| US |
|
Symbotic Inc
NASDAQ:SYM
|
38B USD | -4 780.8 | -3 594.6 | |
| US |
R
|
Reddit Inc
NYSE:RDDT
|
31.3B USD | 63.6 | 59.6 |
Market Distribution
| Min | 0 |
| 30th Percentile | 7 |
| Median | 10.2 |
| 70th Percentile | 14.5 |
| Max | 13 731.1 |
Other Multiples
Solarvest Bioenergy Inc
Glance View
Solarvest BioEnergy, Inc. is an algae biotechnology company, which engages in the development of algal-based production systems. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2006-08-04. The principal business of the Company is the development of its algae-based production systems to develop and commercialize human health products and clean energy. The firm through has its subsidiary developed an algae-based production platform, which is capable of producing various products from Omega 3 fatty acids to human therapeutic proteins. The firm has developed its plant-based organic Omega 3 fatty acids that are rich in Docosahexaenoic Acid/ Eicosapentaenoic Acid (DHA/EPA). Its solar harvesting technology uses the sun, algae, and water to produce clean fuel with no carbon dioxide (CO2) footprint. The company has also initiated a program for the expression of cannabidiol (CBD) and tetrahydrocannabinol (THC) to be produced in good manufacturing practices (GMP) fermentation facilities. Its subsidiaries include Phycobiologics (Europe) Limited, Eversea America Inc., and Eversea Inc.
